Pharmablock Sciences(Nanjing) Inc.’s Net Profit Dropped 41% in First Three Quarters of 2023

Pharmablock Sciences(Nanjing) Inc. (南京药石科技股份有限公司) (300725.SZ) reported a net profit of 154 million yuan in the first three quarters of 2023, down 41% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 9% year-on-year.

At the end of the reporting period, it had 5.2 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 46.2%.